查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1632574

全球临床实验管理服务市场：市场规模、份额和趋势分析（按服务、适应症、最终用途、地区和细分，2025-2030 年）

Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

临床实验管理服务市场的成长与趋势：

根据Grand View Research, Inc.的新报告，全球临床实验管理服务市场规模预计到2030年将达到538.5亿美元。

预计 2025 年至 2030 年期间市场复合年增长率为 8.26%。临床实验活动外包趋势日益增长、尖端治疗研发活性化以及临床实验的全球化是推动市场成长的一些主要因素。

在过去 20 年中，临床实验的数量显着增加。其背景是，对疗效较高的新型药品的需求不断增加，以及尖端医疗技术的普及。根据 clinical trials.gov 的数据，2020 年的临床实验总数为 325,773 项，而截至 2022 年 4 月，今年的临床实验总数超过 410,903 项。

我们的临床临床实验管理服务包括临床监测、资料管理、现场监测和医学写作服务，既经济高效又节省时间。它们还能协调各中心之间的临床资料并降低失败率。此外，云端运算、人工智慧（AI）、巨量资料处方、预测分析、医疗物联网和行动技术等数位技术的整合仍在大力发展。这些技术在提高生产力的同时加快临床实验的步伐，显示出巨大的潜力。

新冠肺炎疫情对市场产生了重大影响。 COVID-19 疫情对市场产生了重大影响，导致对开展临床实验试验和限制现场监测访问的替代解决方案的需求出乎意料的紧迫。为了限制 COVID-19 的传播并保持临床研究的正常进行，研究人员已经转向远端临床实验监控服务和平台。例如，2020 年佛罗伦萨的一项调查发现，超过 60% 的临床实验地点和临床实验申办方表示，他们对临床研究远端站点监控解决方案的接受度超过 50%。

临床实验管理服务市场：分析概述

  • 2024 年临床实验试验监测领域将主导临床实验管理服务业。
  • 2024 年，肿瘤学领域将主导临床实验管理服务业。成长的主要驱动力是对癌症研发的投入增加、癌症发生率的上升、对个人化药物治疗的需求增加，以及肿瘤学领域创新发展的激增。
  • 2024 年的临床实验管理服务业将以製药业为主导。这在很大程度上归功于过去二十年来研发投入和开发新药的增加。
  • 北美主导临床实验管理服务市场。对新治疗方法和新药的需求导致全部区域临床实验数量激增。

目录

第一章 分析方法及范围

第 2 章执行摘要

第三章临床实验管理服务市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 临床实验管理服务市场：分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章临床实验管理服务市场：按服务分類的估计和趋势分析

  • 细分仪表板
  • 全球临床实验管理服务市场：按服务进行变化分析
  • 全球临床实验管理服务市场规模与趋势分析（按服务划分）（2018-2030 年）
  • 临床实验监测
  • 监管提交
  • 临床实验资料管理
  • 医学写作
  • 网站管理
  • 计划管理
  • 其他的

第 5 章临床实验管理服务市场：按适应症进行的估计和趋势分析

  • 细分仪表板
  • 全球临床实验管理服务市场：依适应症进行变化分析
  • 全球临床实验管理服务市场规模与趋势分析（按适应症划分）（2018-2030 年）
  • 自体免疫/炎症
  • 疼痛管理
  • 肿瘤学
  • 中枢神经系统疾病
  • 糖尿病
  • 肥胖
  • 心血管
  • 其他的

第六章临床实验管理服务市场：依最终用途的估计与趋势分析

  • 细分仪表板
  • 全球临床实验管理服务市场：按最终用途进行的变化分析
  • 全球临床实验管理服务市场规模和趋势分析（按最终用途）（2018-2030 年）
  • 药品
  • 生物製药
  • 医疗设备

第七章临床实验管理服务市场：区域估计与趋势分析

  • 区域市场仪表板
  • 全球市场概况：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
    • 市场领导
    • 新兴企业
  • 公司市场地位分析
  • 公司简介
    • CTI Clinical Trial &Consulting
    • Charles River Laboratories
    • Medpace Holdings, Inc.
    • Wuxi Apptec
    • SGS Societe Generale de Surveillance SA
    • Laboratory Corporation of America Holdings
    • IQVIA, Inc.
    • Syneous Health
    • Atlantic Research Group
    • ICON Plc
Product Code: GVR-4-68039-993-8

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 53.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.26% from 2025 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

  • The clinical trial monitoring segment dominated the clinical trial management services industry in 2024.
  • The oncology segment dominated the clinical trial management services industry in 2024. The rise in oncology R&D investments, the increasing cancer incidences, and the growing demand for personalized medications, coupled with a surge in innovative developments in the field of oncology, are the key factors driving the growth.
  • The pharmaceuticals segment dominated the clinical trial management services industry in 2024. This can be largely attributed to the rise in R&D investments and the development of new drugs over the past two decades.
  • North America dominated the clinical trial management services market. The demand for new therapies and drugs has led to a surge in clinical trials across the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing technological advancement in the clinical trial monitoring services
      • 3.2.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
      • 3.2.1.3. Growth in the number of outsourced projects related to clinical trial management services
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with clinical trial management services
      • 3.2.2.2. Stringent regulatory policies for clinical trial management services
  • 3.3. Clinical Trial Management Services Market: Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Management Services Market: Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Management Services Market, Services Movement Analysis
  • 4.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
  • 4.4. Clinical Trial Monitoring
    • 4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.5. Regulatory Submissions
    • 4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.6. Clinical Trial Data Management
    • 4.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.7. Medical Writing
    • 4.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.8. Site Management
    • 4.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.9. Project Management
    • 4.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Management Services Market, Indication Movement Analysis
  • 5.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Autoimmune/Inflammation
    • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.5. Pain Management
    • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.7. CNS Conditions
    • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.8. Diabetes
    • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.9. Obesity
    • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.10. Cardiovascular
    • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Clinical Trial Management Services Market, End Use Movement Analysis
  • 6.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceuticals
    • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.5. Biopharmaceuticals
    • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.6. Medical Devices
    • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Company Market Position Analysis
  • 8.3. Company Profiles
    • 8.3.1. CTI Clinical Trial & Consulting
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Charles River Laboratories
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Medpace Holdings, Inc.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Wuxi Apptec
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. SGS Societe Generale de Surveillance SA
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Laboratory Corporation of America Holdings
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. IQVIA, Inc.
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Syneous Health
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Atlantic Research Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. ICON Plc
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Management Services, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 12 U.S. Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 18 Mexico Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 19 Mexico Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 22 Europe Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Europe Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 26 Germany Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 27 UK Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 28 UK Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 29 UK Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 32 France Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 40 Denmark Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 41 Denmark Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 43 Sweden Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 44 Sweden Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 52 China Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 53 China Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 54 China Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Japan Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 56 Japan Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 57 Japan Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 59 India Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 60 India Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 62 South Korea Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 63 South Korea Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Australia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 65 Australia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 66 Australia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 68 Thailand Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 69 Thailand Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 72 Latin America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 73 Latin America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 75 Brazil Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 76 Brazil Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 86 South Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 92 UAE Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Management Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Porter's Five Forces Analysis
  • Fig. 10 PESTEL Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Management Services, for Clinical Trial Monitoring, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Management Services, for Regulatory Submissions, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Management Services, for Clinical Trial Data Management, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Management Services, for Medical Writing, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Management Services, for Site Management, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Management Services, for Project Management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Management Services, for Autoimmune/Inflammation, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Management Services, for Pain Management, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Management Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Management Services, for CNS Conditions, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Management Services, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Management Services, for Obesity, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Management Services, for Cardiovascular, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Clinical Trial Management Services, for Pharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Management Services, for Biopharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Management Services, for Medical Devices, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 North America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 US Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)